Literature DB >> 25131214

Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.

A Chaudhry1, A Noor2,3, B Degagne3, K Baker4,5, L A Bok6, A F Brady7, D Chitayat1,8, B H Chung9, C Cytrynbaum1,10, D Dyment11, I Filges12, B Helm13, H T Hutchison14, L J B Jeng15, F Laumonnier16, C R Marshall17, M Menzel18, S Parkash19,20, M J Parker21, L F Raymond4,5, A L Rideout19, W Roberts22, R Rupps23, I Schanze24, C T R M Schrander-Stumpel25, M D Speevak26, D J Stavropoulos2,17, S J C Stevens25, E R A Thomas27, A Toutain16,28, S Vergano13, R Weksberg1,29,30, S W Scherer17,29,30, J B Vincent3,29,31, M T Carter1,22.   

Abstract

Studies of genomic copy number variants (CNVs) have identified genes associated with autism spectrum disorder (ASD) and intellectual disability (ID) such as NRXN1, SHANK2, SHANK3 and PTCHD1. Deletions have been reported in PTCHD1 however there has been little information available regarding the clinical presentation of these individuals. Herein we present 23 individuals with PTCHD1 deletions or truncating mutations with detailed phenotypic descriptions. The results suggest that individuals with disruption of the PTCHD1 coding region may have subtle dysmorphic features including a long face, prominent forehead, puffy eyelids and a thin upper lip. They do not have a consistent pattern of associated congenital anomalies or growth abnormalities. They have mild to moderate global developmental delay, variable degrees of ID, and many have prominent behavioral issues. Over 40% of subjects have ASD or ASD-like behaviors. The only consistent neurological findings in our cohort are orofacial hypotonia and mild motor incoordination. Our findings suggest that hemizygous PTCHD1 loss of function causes an X-linked neurodevelopmental disorder with a strong propensity to autistic behaviors. Detailed neuropsychological studies are required to better define the cognitive and behavioral phenotype.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PTCHD1; X-linked; autism spectrum disorder; intellectual disability; phenotype

Mesh:

Substances:

Year:  2014        PMID: 25131214     DOI: 10.1111/cge.12482

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  28 in total

1.  Next Generation Sequencing and Health Technology Assessment in Autism Spectrum Disorder.

Authors:  Wendy J Ungar
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2015-08-31

2.  Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability.

Authors:  Bàrbara Torrico; Noèlia Fernàndez-Castillo; Amaia Hervás; Montserrat Milà; Marta Salgado; Isabel Rueda; Jan K Buitelaar; Nanda Rommelse; Anoek M Oerlemans; Janita Bralten; Christine M Freitag; Andreas Reif; Agatino Battaglia; Luigi Mazzone; Elena Maestrini; Bru Cormand; Claudio Toma
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 3.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

4.  Combinatorial Targeting of Distributed Forebrain Networks Reverses Noise Hypersensitivity in a Model of Autism Spectrum Disorder.

Authors:  Miho Nakajima; L Ian Schmitt; Guoping Feng; Michael M Halassa
Journal:  Neuron       Date:  2019-10-21       Impact factor: 17.173

Review 5.  Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?

Authors:  Chelsea Lowther; Gregory Costain; Danielle A Baribeau; Anne S Bassett
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

Review 6.  Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental Disorders.

Authors:  Alexandra Krol; Ralf D Wimmer; Michael M Halassa; Guoping Feng
Journal:  Neuron       Date:  2018-04-18       Impact factor: 17.173

7.  A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders.

Authors:  Andrea J Gonzalez-Mantilla; Andres Moreno-De-Luca; David H Ledbetter; Christa Lese Martin
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

8.  Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  A G Sandoval-Hernández; H G Hernández; A Restrepo; J I Muñoz; G F Bayon; A F Fernández; M F Fraga; G P Cardona-Gómez; H Arboleda; Gonzalo H Arboleda
Journal:  J Mol Neurosci       Date:  2015-11-09       Impact factor: 3.444

9.  Neuroscience: Untangling autism.

Authors:  Scott Bolkan; Joshua A Gordon
Journal:  Nature       Date:  2016-03-23       Impact factor: 49.962

10.  Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS.

Authors:  P Joel Ross; Wen-Bo Zhang; Rebecca S F Mok; Kirill Zaslavsky; Eric Deneault; Lia D'Abate; Deivid C Rodrigues; Ryan K C Yuen; Muhammad Faheem; Marat Mufteev; Alina Piekna; Wei Wei; Peter Pasceri; Rebecca J Landa; Andras Nagy; Balazs Varga; Michael W Salter; Stephen W Scherer; James Ellis
Journal:  Biol Psychiatry       Date:  2019-07-29       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.